WHO ICTRP trial

Clinical and Mechanistic Study on Lianshi Jianpi Formula Regulating 'Gut…

ITMCTR2025001024 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting

Key facts

Trial ID ITMCTR2025001024
Public title Clinical and Mechanistic Study on Lianshi Jianpi Formula Regulating 'Gut Microbiota-Macrophage Polarization Axis' to Improve Phlegm-Dampness Constitution Metabolic Dysfunction-Associated Fatty Liver Disease
Scientific title Clinical and Mechanistic Study on Lianshi Jianpi Formula Regulating 'Gut Microbiota-Macrophage Polarization Axis' to Improve Phlegm-Dampness Constitution Metabolic Dysfunction-Associated Fatty Liver Disease
Primary sponsor People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase Pilot clinical trial
Countries China
Conditions Metabolic Dysfunction-Associated Fatty Liver Disease
Interventions Control group:lifestyle intervention;Healthy control group:No;Treatment group:Lifestyle intervention combined with Lianshi Jianpi Formula
Registration date May 24, 2025
Target size Control group:33;Healthy control group:20;Treatment group:33
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations